PORTLAND, ME, MedRhythms, a company using sensors, software, and music to improve patients with neurological illnesses ability to walk, has raised $25 million in series B financing.
MedRhythms, a digital therapeutics platform, has recently raised $25 million in series B funding led by Morningside Ventures and Advantage Capital and Werth Family Investment Associates.
The company uses sensors, music, and other software to improve walking in patients with neurological conditions or diseases.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
